Dr. Armand Balboni, MD, PhD, JD
Dr. Balboni is a partner, senior advisor and member of the Board of Directors of Bloom Burton & Co.
Armand acts as Bloom Burton’s senior most advisor on scientific, regulatory and medical affairs for our incubated companies and clients. He recently completed a period of active duty in the U.S. Army as the Deputy Director, Office of Regulated Activities (ORA) and senior reviewer on their clinical pharmacovigilance team. ORA and its 80-person team provide clinical and regulatory oversight and advisement for more than 100 FDA clinical trials and all associated regulatory filings and meeting necessary for approval. Special emphasis was placed on regulatory filings (EUAs, meetings, pre-sub filings etc.) for military relevant products across all therapeutic areas including vaccines, devices, biologics, and small molecule drugs.
Dr. Balboni completed a DoD fellowship at the U.S. FDA, CDER, Division of Anti-infective Products, and in the Office of the Commissioner and the Office of Counterterrorism and Emerging Threats (OCET). He also served as the Chief, Office of Research and Technology Application (ORTA) at the U.S. Army Research Institute of Infectious Disease (USAMRIID). His office was tasked with oversight of all strategic partnerships between USAMRIID and universities, U.S. and foreign government agencies, and biotechnology and pharmaceutical companies.
Dr. Balboni has held various academic teaching positions including at Westfield State University, the University of Maryland University college, and the United States Military Academy at West Point. He completed his graduate doctoral work at the Icahn School of Medicine at Mount Sinai and his law degree at Brooklyn Law School.
